Major Shareholder Announcement
01-10-09 kl. 1/10 2009 00:00 | Veloxis Pharmaceuticals 0,90 (+4,65%)
Hørsholm, Denmark, October 1 2009; In accordance with Section 29 of the Securities Trading Act LifeCycle Pharma A/S (OMX: LCP) today announced that LCP has received a notification from ATP and ATP Invest that it after sale has shareholdings in LCP of 2,823,699 shares of nom. DKK 1, corresponding to 4.99% of the share capital and the voting rights in LCP.
Der er endnu ikke skrevet nogen kommentarer til denne artikel.
Skriv en kommentarer til denne artikel:
Send kommentar
Skriv en kommentarer til denne artikel:
Send kommentar

Se flere nyheder om Veloxis Pharmaceuticals



